Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 September 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Repeat biopsy after celiac disease diagnosis does not affect long-term outcomes

Performing routine follow-up biopsy 1 year after diagnosis does not affect long-term outcomes in celiac disease, reports June's issue of the Alimentary Pharmacology & Therapeutics.

News image

A repeat biopsy is recommended, but often omitted in coeliac disease patients on a gluten-free diet. 

The effect of performing or not performing repeat biopsies is currently unknown.

Dr Kurppa and colleagues from Finland identified factors associated with, and the significance of lacking biopsy for long-term outcome. 

Predictors and the importance of incomplete histological recovery after 1 year was investigated in re-biopsied patients.

A total of 760 patients participated in a nationwide follow-up study. 

The research team collected medical data via interviews and patient records, and blood samples were drawn for serology. 

Incomplete mucosal recovery was predicted by more advanced histological disease at diagnosis
Alimentary Pharmacology & Therapeutics
Current symptoms and well-being were assessed by validated PGWB, SF-36 and GSRS questionnaires.

The researchers found that malabsorption was more common among those with a repeat biopsy than those without repeat biopsy.

The team also found that severe symptoms at diagnosis, and concomitant gastrointestinal or musculoskeletal diseases such as arthritis, osteoporosis and back pain were more common among those with a repeat biopsy. 

The team observed that repeat biopsy was more rare in subjects diagnosed in private care or by screening. 

The groups were comparable as to current symptoms and dietary adherence, but those without re-biopsy were less confident of their diet, and more often seropositive on diet. 

The team reported better SF-36 physical functioning, and less pain and indigestion, and total GSRS score. 

The research team found that incomplete mucosal recovery was predicted by more advanced histological and serological disease at diagnosis, whereas the groups did not differ in long-term adherence, symptoms, seropositivity, questionnaire scores, frequency of fractures or malignancies.

Dr Kurppa's team concludes, "Severe disease at diagnosis predicted the record of a repeat biopsy and incomplete mucosal recovery."

"Neither lacking biopsy nor incomplete recovery in a relative short time span of 1 year was associated with poorer long-term outcome, although survival bias cannot be excluded."

Aliment Pharmacol Ther 2017: 45(11): 1459–1468
19 June 2017

Go to top of page Email this page Email this page to a colleague

 22 September 2017 
MRI for liver metastatic colorectal cancer
 22 September 2017 
Perforation after colonic endoscopic mucosal resection
 22 September 2017 
Medical management and colectomy rates
 21 September 2017 
Predicting mucosal healing in treated celiac disease patients
 21 September 2017 
Antireflux surgery and recurrence of GERD
 21 September 2017 
Adenomatous colorectal polyps in young cancer survivors
 20 September 2017 
Rifaximin and spontaneous bacterial peritonitis in cirrhosis
 20 September 2017 
Omega-3 PUFA and colorectal cancer survival
 20 September 2017 
Beta-blockers and cardiopulmonary exercise testing in liver disease
 19 September 2017 
Birth outcomes in children fathered by men treated with azathioprine
 19 September 2017 
Risk of death and statins in alcoholic cirrhosis
 19 September 2017 
Hospital-readmission risk
 18 September 2017 
Ethnic disparities and Hep C survival
 18 September 2017 
Depression and celiac disease in the USA
 18 September 2017 
Health care services in IBD
 15 September 2017 
Hemidesmosome integrity and colorectal cancer
 15 September 2017 
Herpes zoster vaccination in IBD
 15 September 2017 
Chronic pancreatitis and pancreatic cancer risk
 14 September 2017 
National survey on stopping PPIs
 14 September 2017 
Psychological impact of IBD
 14 September 2017 
Bile tree pathology in patients presenting with gallbladder disease
 13 September 2017 
Predicting clinical outcome in colorectal cancer
 13 September 2017 
Oral contraceptives increases the risk of IBD
 13 September 2017 
Mortality in cirrhosis
 12 September 2017 
Genetic factors and tobacco in IBD
 12 September 2017 
Predictors of colectomy in ulcerative colitis
 12 September 2017 
Low birthweight and pediatric NAFLD
 11 September 2017 
Proteomic analysis of IBD
 11 September 2017 
New therapies to manage Hep B
 11 September 2017 
Ethnic disparities for chronic Hep C survival
 08 September 2017 
Antibiotics and diverticulitis
 08 September 2017 
Improving adherence to colorectal cancer screening
 08 September 2017 
Preoperative workup for colorectal cancer
 07 September 2017 
Laparoscopic surgery use in Medicare patients with colon cancer
 07 September 2017 
Outreach to improve colorectal cancer screening
 07 September 2017 
Nicotine chewing gum after colorectal surgery
 06 September 2017 
Novel candidate risk genes for IBD
 06 September 2017 
PPI use and chronic kidney disease
 06 September 2017 
Colorectal cancer surgery in the very elderly patient
 05 September 2017 
Unprovoked Venous Thromboembolism and occult cancer
 05 September 2017 
Hep E seroprevalence and hemodialysis
 05 September 2017 
Antibody tests and detecting celiac disease
 04 September 2017 
Acute pancreatitis and health related quality of life
 04 September 2017 
Infliximab treatment and eHealth in IBD
 04 September 2017 
Contrast-enhanced ultrasound for diagnosis of liver cancer
 01 September 2017 
Late recurrence of Barrett’s esophagus after eradication
 01 September 2017 
Thalidomide ine children with IBD
 01 September 2017 
Occult cancer screening with unprovoked venous thromboembolism
 31 August 2017 
Asthma and IBD development
 31 August 2017 
Environmental factors and IBD
 31 August 2017 
Management of noncardiac chest pain
 30 August 2017 
Diet and increased flares in patients with ulcerative colitis in remission
 30 August 2017 
Induction of remission in pediatric Crohn's disease
 29 August 2017 
Reducing antibody formation against TNF antagonists in IBD
 29 August 2017 
Epidemiological changes of chronic hepatitis
 28 August 2017 
Hyperuricemia and NAFLD activity score
 28 August 2017 
Therapy for acute variceal hemorrhage
 28 August 2017 
Colectomy rates in ulcerative colitis
 25 August 2017 
Making personalized nutrition a reality
 25 August 2017 
Predicting advanced colorectal cancer survival

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us